EATG » Hepatitis

Hepatitis

Countries risk ‘running out’ of hepatitis C patients to treat, says World Hepatitis Alliance

The latest data on the global hepatitis C epidemic, released at the World Hepatitis Summit in Sao Paulo, Brazil (1-3 November) reveal that most countries (especially high-income countries) are running…

UK elimination of hepatitis C in jeopardy unless more patients found

New data show that more than 100,000 people living with hepatitis C in the UK are undiagnosed Just one in three people with hepatitis C in the United Kingdom have…

Only half of people in USA living with curable cancer-causing disease are aware

New data released at this year's World Hepatitis Summit in Sao Paulo, Brazil (1-3 November) show that out of an estimated 2.7 million (1) people now living with hepatitis C…

Close to 3 million people access hepatitis C cure

World Hepatitis Summit 2017 calls for accelerated action to eliminate viral hepatitis 31 October 2017 | São Paulo, Brazil - On the eve of the World Hepatitis Summit in Brazil,…

MSF secures generic hepatitis C treatment at $120 compared to $147,000 launch price tag

Geneva/Sao Paolo, 31 October 2017—On the eve of the World Hepatitis Summit in Sao Paolo, the international medical humanitarian organization Médecins Sans Frontières (MSF) today announced that it had secured…

Hepatitis C test-and-treat programme reduces HCV by two-thirds among men who have sex with men in Swiss HIV Cohort

A systematic policy of test-and-treat cured 99% of men who have sex with men with hepatitis C in the Swiss HIV Cohort in an 8-month period and reduced the prevalence…

High rate of hepatitis C reinfection in German men who have sex with men

Around one in seven gay and bisexual men cured of hepatitis C at major treatment centres in Germany has become reinfected since 2014, according to findings from the German Hepatitis…

EACS 2017: NATAP reports

The 16th European AIDS Conference (EACS 2017) took place on 25-27 October 2017 in Milan, Italy. NATAP reports: Switch to boosted PI/3TC noninferior to triple therapy in 4-trial analysis Meta-analysis…

Fatty liver common after direct-acting antivirals for hep C

WASHINGTON, DC — Evidence of steatosis is found in almost half the patients with hepatitis C who achieved a sustained virologic response after treatment with direct-acting antivirals, results from a prospective…

Hepatitis C halved in Spanish people living with HIV in one year due to treatment

Spain is making dramatic progress towards eliminating hepatitis C in people living with HIV because of widespread use of direct-acting antivirals, Juan Berenguer of Hospital Gregorio Marañón, Madrid, reported on…